Risky Research Review Act This bill establishes the Life Sciences Research Security Board to oversee the award of federal funding for high-risk life sciences research. High-risk life sciences research means the study of an organism, virus, or related product that could be misapplied to pose a significant threat to the public or could enhance the transmissibility or virulence of certain high-risk pathogens (e.g., Ebola). Specifically, the bill establishes the board as an independent agency that must review proposed high-risk life sciences research, determine whether a federal agency may award funding for the research, and determine minimum required controls for funded research. Entities that are seeking federal funding must attest to whether their research is high-risk life sciences research. Agencies must certify the validity of these attestations and submit proposed high-risk life sciences research to the board. Agencies must also notify the board of intended awards for other life sciences research for potential review. In making its determinations, the board must consider specified factors, including whether the benefits of the research outweigh the risks. The bill prohibits agencies from awarding federal funding for high-risk life sciences research without approval of the board or for life sciences research currently under board review. The board may also review awards that were made before the bill’s enactment. Entities that fail to properly attest to the nature of their research may lose their eligibility for funding. Additionally, agency employees who fail to comply with the bill's requirements are subject to disciplinary action.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.
Gilbert Ray Cisneros, Jr. bought K
Bill introduced
Robert P. Bresnahan, Jr. bought K
Lobbying filed by BIOTECHNOLOGY INNOVATION ORGANIZATION
Lobbying filed by ASSOCIATION OF AMERICAN MEDICAL COLLEGES
Committee on Homeland Security and Governmental Affairs. Reported by Senator Paul without amendment. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.
View official actionCommittee on Homeland Security and Governmental Affairs. Reported by Senator Paul without amendment. Without written report.
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | $89.0M | Apr 21, 2025 | 2025Q1 | AGRANIBUD |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | $83.1M | Jul 17, 2025 | 2025Q2 | ANIBUDEDU |
Congress members who traded stocks in companies connected to lobbying on this bill, within 90 days of its introduction date.
| Member | Party | Ticker | Company | Trade | Date | Amount | Timing | Lobbying Client | Conflict |
|---|---|---|---|---|---|---|---|---|---|
| Robert P. Bresnahan, Jr. | R | K | K | Buy | Apr 8, 2025 | $1,001 - $15,000 | 34d after | JOHNS HOPKINS UNIVERSITY | 37% |
| Gilbert Ray Cisneros, Jr. | D |
3 trades by 2 members of Congress in companies connected to lobbying on S 854. The average conflict score is 35%.
CapitolExposed identifies the "bill-lobbying-trade pipeline" by: (1) finding lobbying filings (LD-2) that specifically mention this bill, (2) matching lobbying clients to publicly traded companies, and (3) finding stock trades by members of Congress in those companies within 90 days of the bill's introduction date. Trades made before the bill was introduced are highlighted in red, as they may indicate advance knowledge. This analysis surfaces correlations worthy of scrutiny; it does not prove wrongdoing.
Lobbying filed by UNIVERSITY OF MICHIGAN
Gilbert Ray Cisneros, Jr. bought K
Lobbying filed by ASSOCIATION OF AMERICAN MEDICAL COLLEGES
Lobbying filed by AMERICAN FED OF GOVERNMENT EMPLOYEES AFL-CIO
Committee on Homeland Security and Governmental Affairs. Ordered to be reported without amendment favorably.
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES |
| $75.1M |
| Apr 21, 2025 |
| 2025Q1 |
ANIIMMTAX |
| AMERICAN FED OF GOVERNMENT EMPLOYEES, AFL-CIO | AMERICAN FED OF GOVERNMENT EMPLOYEES AFL-CIO | $59.0M | Jul 30, 2025 | 2025Q2 | CIVDEFDOC |
| UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | $25.0M | Apr 21, 2025 | 2025Q1 | TRABUDEDU |
| JOHNS HOPKINS UNIVERSITY | JOHNS HOPKINS UNIVERSITY | $17.0M | Apr 21, 2025 | 2025Q1 | BUDHCRSCI |
| MICHIGAN STATE UNIVERSITY | MICHIGAN STATE UNIV | $12.0M | Apr 21, 2025 | 2025Q1 | AGRARTCOM |
| UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | $11.0M | Jul 21, 2025 | 2025Q2 | SCIBUDEDU |
| MICHIGAN STATE UNIVERSITY | MICHIGAN STATE UNIV | $10.0M | Jul 22, 2025 | 2025Q2 | COMAGRART |
| RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | $10.0M | Jul 21, 2025 | 2025Q2 | BUDSCITAX |
| RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | $10.0M | Apr 21, 2025 | 2025Q1 | BUDSCITAX |
| BOSTON UNIVERSITY | BOSTON UNIVERSITY | $8.0M | Apr 10, 2025 | 2025Q1 | BUDEDUDEF |
| AMERICAN SOCIETY FOR MICROBIOLOGY | AMERICAN SOCIETY FOR MICROBIOLOGY | $5.0M | Jul 15, 2025 | 2025Q2 | HCRBUDSCI |
| AKIN GUMP STRAUSS HAUER & FELD | UNIVERSITY OF LOUISVILLE | $5.0M | Apr 21, 2025 | 2025Q1 | BUDDEFHCR |
| AMERICAN SOCIETY FOR MICROBIOLOGY | AMERICAN SOCIETY FOR MICROBIOLOGY | $5.0M | Apr 16, 2025 | 2025Q1 | HCRBUDSCI |
| K |
| Buy |
| Jan 24, 2025 |
| $1,001 - $15,000 |
| 40d before |
| JOHNS HOPKINS UNIVERSITY |
| 32% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Apr 29, 2025 | $1,001 - $15,000 | 55d after | JOHNS HOPKINS UNIVERSITY | 36% |